PCCA's Clinical Services team is populated with hard-working, dedicated pharmacy professionals who strive each day to make a difference in pharmacy compounding. As a team, they act as a cornerstone of PCCA's abiding desire to provide pharmacies with answers to tough questions. The Clinical Services Spotlight is a limited series of articles designed to highlight a singular member of the Clinical Services team. This article focuses on Matt Martin, PharmD, a man destined to wear PCCA blue.

Yi Liu, PCCA Research Pharmacist, provides an exciting update regarding new therapies, the extension of beyond-use dates (BUDs) for compounding formulations, evaluating compounding equipment and a whole lot more in this PCCA Science Update!

Establishing yourself as a men's health consultant can be a differentiating factor between yourself and your competitors. Between HRT, prostate health and supplementation, Bruce Biundo of PCCA Clinical Services is happy to provide methods you can use to establish yourself as the authoritative voice on men's health to those in your area.

Don Bottoni, RPh, FACA, a PCCA Clinical Compounding Pharmacist provides two tests that can help pharmacies to test the quality of their Dimethyl sulfoxide (DMSO) to ensure they are using high-quality, USP-grade DMSO.

Congratulations to Rachelle Whitaker, CPhT, for being our January Profile in Personalized Medicine. These profiles celebrate members of the PCCA family who have proven to be champions of Pharmacy Compounding by providing the highest quality of service to their patients.

PCCA's Matt Martin and Melissa Merrell Rhoads provide an update on the FDA's decision to designate human chorionic gonadotropin (HCG) as a biologic product and what that means for compounders and for PCCA.